•
Jun 30, 2018

Emergent BioSolutions Q2 2018 Earnings Report

Total Revenue
$220M
Previous year: $101M
+118.5%
EPS
$1.07
Previous year: $0.11
+872.7%
Gross Profit
$131M
Previous year: $66.1M
+98.1%
Cash and Equivalents
$190M
Previous year: $316M
-39.7%
Free Cash Flow
$21M
Previous year: $44.7M
-53.1%
Total Assets
$1.14B
Previous year: $970M
+17.4%

Emergent BioSolutions

Emergent BioSolutions